Johnson & Johnson Expects 2024 Adjusted EPS Of $9.88–$9.98 Compared To Prior Guidance Of $9.97-$10.07 And Consensus Of $9.84
Portfolio Pulse from Benzinga Newsdesk
Johnson & Johnson has revised its 2024 adjusted EPS guidance to $9.88–$9.98, down from the previous $9.97-$10.07, but still above the consensus of $9.84.
October 15, 2024 | 10:27 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Johnson & Johnson has adjusted its 2024 EPS guidance to $9.88–$9.98, which is a slight decrease from the previous range but remains above the consensus estimate.
The revision in EPS guidance is slightly lower than the previous guidance, which could be seen as a negative. However, it is still above the consensus estimate, which may mitigate negative sentiment. The impact on stock price is likely neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100